Reduction of serum HCV RNA titer by bezafibrate therapy in patients with chronic hepatitis C [2]

American Journal of Gastroenterology

Volumn 99, Issue 11, 2004, Pages 2280-

  Fujita, Naoki ^a   Kaito, Masahiko ^a   Tanaka, Hideaki ^a   Horiike, Shinichiro ^a   Adachi, Yukihiko ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BEZAFIBRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERFERON; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; RIBAVIRIN; TRIACYLGLYCEROL; VIRUS RNA;

ADULT; AGED; CHOLESTEROL BLOOD LEVEL; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; ERADICATION THERAPY; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOPRECIPITATION; LETTER; MALE; PILOT STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; VIRUS TITRATION;

ADULT; AGED; ANTILIPEMIC AGENTS; BEZAFIBRATE; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; RNA, VIRAL;

EID: 19644401237     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.40695_3.x     Document Type: Letter

References (5)

1. Di Bisceglie AM. Natural history of hepatitis C: Its impact on clinical management. Hepatology 2000;31:1014-8.
2. McHutchison JG, Gordon SC, Schiff ER, et al. for the International Hepatitis Interventional Therapy Group. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998;339:1485-92.
3. Thomssen R, Bonk S, Propfee C, et al. Association of hepatitis C virus in human sera with beta lipoprotein. Med Microbiol Immunol 1992;181:293-300.
4. Fujita N, Kaito M, Takeo M, et al. Different hepatitis C virus dynamics of free-virions and immune-complexes after initiation of interferon-α in patients with chronic hepatitis C. J Hepatol 2003;29:1013-9.
5. Kurihara T, Niimi A, Maeda A, et al. Bezafibrate in the treatment of primary biliary cirrhosis: Comparison with ursodeoxycholic acid. Am J Gastroenterol 2002;95:2990-2.